Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Autor:	William Alexander, Terrence H. Diamond, Rajeev Ramakrishna, Terry Golombick, Arumugam Manoharan
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	medicine.medical_treatment Immunomodulatory drug lcsh:Medicine Case Report Case Reports 030204 cardiovascular system & hematology Pharmacology Steroid 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine curcumin Adverse effect Multiple myeloma lcsh:R5-920 business.industry lcsh:R General Medicine medicine.disease multiple myeloma Regimen Steroid therapy chemistry 030220 oncology & carcinogenesis Proteasome inhibitor Curcumin dexamethasone intolerance business lcsh:Medicine (General) medicine.drug
Zdroj:	Clinical Case Reports, Vol 8, Iss 4, Pp 739-744 (2020) Clinical Case Reports
ISSN:	2050-0904
Popis:	Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feecd140b0ec02a7c5b2ca18dbf8dfbf https://doaj.org/article/0f7c75bb1dbe4aeca6c4a42b462bc37c Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.